Correlation Between Scpharmaceuticals and 180 Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Scpharmaceuticals and 180 Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scpharmaceuticals and 180 Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scpharmaceuticals and 180 Life Sciences, you can compare the effects of market volatilities on Scpharmaceuticals and 180 Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scpharmaceuticals with a short position of 180 Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scpharmaceuticals and 180 Life.

Diversification Opportunities for Scpharmaceuticals and 180 Life

-0.16
  Correlation Coefficient

Good diversification

The 3 months correlation between Scpharmaceuticals and 180 is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Scpharmaceuticals and 180 Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on 180 Life Sciences and Scpharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scpharmaceuticals are associated (or correlated) with 180 Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of 180 Life Sciences has no effect on the direction of Scpharmaceuticals i.e., Scpharmaceuticals and 180 Life go up and down completely randomly.

Pair Corralation between Scpharmaceuticals and 180 Life

Given the investment horizon of 90 days Scpharmaceuticals is expected to under-perform the 180 Life. But the stock apears to be less risky and, when comparing its historical volatility, Scpharmaceuticals is 5.12 times less risky than 180 Life. The stock trades about -0.05 of its potential returns per unit of risk. The 180 Life Sciences is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  2,318  in 180 Life Sciences on August 31, 2024 and sell it today you would lose (2,095) from holding 180 Life Sciences or give up 90.38% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Scpharmaceuticals  vs.  180 Life Sciences

 Performance 
       Timeline  
Scpharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scpharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.
180 Life Sciences 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in 180 Life Sciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, 180 Life reported solid returns over the last few months and may actually be approaching a breakup point.

Scpharmaceuticals and 180 Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Scpharmaceuticals and 180 Life

The main advantage of trading using opposite Scpharmaceuticals and 180 Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scpharmaceuticals position performs unexpectedly, 180 Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 180 Life will offset losses from the drop in 180 Life's long position.
The idea behind Scpharmaceuticals and 180 Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios